A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/17 (2006.01) A61K 35/14 (2006.01) A61K 35/76 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2442648
A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
Cette invention porte sur une méthode de traitement d'un sujet humain atteint d'un cancer. Une composition pharmaceutique est administrée au sujet, laquelle composition comprend des leucocytes humains ainsi qu'un virus oncolytique compétent pour la réplication en suspension dans une solution physiologiquement acceptable. Dans une variante, la composition pharmaceutique comprend des leucocytes ou des plaquettes d'être humain infectés par un virus oncolytique.
Groene William S.
Miller Jeffrey A.
Mueller Stephen N.
Mccarthy Tetrault Llp
Pro-Virus Inc.
Wellstat Biologics Corporation
LandOfFree
Oncolytic virus therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oncolytic virus therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncolytic virus therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1861404